Breast Cancer Subtype Discordance: Impact on Post-Recurrence Survival and Potential Treatment Options

BMC Cancer - United Kingdom
doi 10.1186/s12885-018-4101-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Impact on Survival of Estrogen Receptor, Progesterone Receptor and Ki-67 Expression Discordance Pre- And Post-Neoadjuvant Chemotherapy in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

Impact of Post-Transplant Lymphoproliferative Disorder Subtype on Survival

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Revisiting the Impact of Age and Molecular Subtype on Overall Survival After Radiotherapy in Breast Cancer Patients

Scientific Reports
Multidisciplinary
2017English

Locoregional Recurrence of Early Breast Cancer According to Intrinsic Subtype

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2014English

Breast Cancer Risk Factors, Survival and Recurrence, and Tumor Molecular Subtype: Analysis of 3012 Women From an Indigenous Asian Population

Breast Cancer Research
Cancer ResearchOncology
2018English

Breast Cancer Survival by Immunohistochemistry-Determined Subtype: A Retrospective Study

Gaceta Medica de Mexico
Medicine
2019English

Dietary Patterns and Breast Cancer Recurrence and Survival Among Women With Early-Stage Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

The Impact of Diabetes Treatment on Survival in a Breast Cancer/Diabetes Model

2008English

Age and Survival Estimates in Patients Who Have Node-Negative T1ab Breast Cancer by Breast Cancer Subtype

Clinical Breast Cancer
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy